Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6041152 | Neuromuscular Disorders | 2016 | 33 Pages |
Abstract
The Performance of the Upper Limb scale was developed as an outcome measure specifically for ambulant and non-ambulant patients with Duchenne muscular dystrophy and is implemented in clinical trials needing longitudinal data. The aim of this study is to determine whether this novel tool correlates with functional ability using pulmonary function test, cardiac function test and Egen Klassifikation scale scores as clinical measures. In this cross-sectional study, 43 non-ambulatory Duchenne males from ages 10 to 30 years and on long-term glucocorticoid treatment were enrolled. Cardiac and pulmonary function test results were analyzed to assess cardiopulmonary function, and Egen Klassifikation scores were analyzed to assess functional ability. The Performance of the Upper Limb scores correlated with pulmonary function measures and had inverse correlation with Egen Klassifikation scores. There was no correlation with left ventricular ejection fraction and left ventricular dysfunction. Body mass index and decreased joint range of motion affected total Performance of the Upper Limb scores and should be considered in clinical trial designs.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Ha Neul Lee, Hemant Sawnani, Paul S. Horn, Irina Rybalsky, Lani Relucio, Brenda L. Wong,